These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 17215493)

  • 1. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.
    Dombi E; Solomon J; Gillespie AJ; Fox E; Balis FM; Patronas N; Korf BR; Babovic-Vuksanovic D; Packer RJ; Belasco J; Goldman S; Jakacki R; Kieran M; Steinberg SM; Widemann BC
    Neurology; 2007 Feb; 68(9):643-7. PubMed ID: 17215493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits.
    Nguyen R; Kluwe L; Fuensterer C; Kentsch M; Friedrich RE; Mautner VF
    J Pediatr; 2011 Oct; 159(4):652-5.e2. PubMed ID: 21621223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two Methods.
    Cai W; Steinberg SM; Bredella MA; Basinsky G; Somarouthu B; Plotkin SR; Solomon J; Widemann BC; Harris GJ; Dombi E
    Acad Radiol; 2018 Feb; 25(2):144-152. PubMed ID: 29097016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging.
    Solomon J; Warren K; Dombi E; Patronas N; Widemann B
    Comput Med Imaging Graph; 2004 Jul; 28(5):257-65. PubMed ID: 15249071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice.
    Pratt L; Helfer D; Weizman L; Shofty B; Constantini S; Joskowicz L; Ben Bashat D; Ben-Sira L
    Acta Neurochir (Wien); 2015 May; 157(5):855-61. PubMed ID: 25772343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
    Gross AM; Glassberg B; Wolters PL; Dombi E; Baldwin A; Fisher MJ; Kim A; Bornhorst M; Weiss BD; Blakeley JO; Whitcomb P; Paul SM; Steinberg SM; Venzon DJ; Martin S; Carbonell A; Heisey K; Therrien J; Kapustina O; Dufek A; Derdak J; Smith MA; Widemann BC
    Neuro Oncol; 2022 Nov; 24(11):1978-1988. PubMed ID: 35467749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
    Widemann BC; Babovic-Vuksanovic D; Dombi E; Wolters PL; Goldman S; Martin S; Goodwin A; Goodspeed W; Kieran MW; Cohen B; Blaney SM; King A; Solomon J; Patronas N; Balis FM; Fox E; Steinberg SM; Packer RJ
    Pediatr Blood Cancer; 2014 Sep; 61(9):1598-602. PubMed ID: 24753394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1.
    Lim R; Jaramillo D; Poussaint TY; Chang Y; Korf B
    AJR Am J Roentgenol; 2005 Mar; 184(3):962-8. PubMed ID: 15728625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.
    Kim A; Gillespie A; Dombi E; Goodwin A; Goodspeed W; Fox E; Balis FM; Widemann BC
    Neurology; 2009 Oct; 73(16):1273-9. PubMed ID: 19841379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.
    Ahlawat S; Ly KI; Fayad LM; Fisher MJ; Lessing AJ; Berg DJ; Salamon JM; Mautner VF; Babovic-Vuksanovic D; Dombi E; Harris G; Plotkin SR; Blakeley J;
    Neurology; 2021 Aug; 97(7 Suppl 1):S111-S119. PubMed ID: 34230200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
    Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
    Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of NF1-related plexiform neurofibroma to high-dose carboplatin.
    Hummel T; Anyane-Yeboa A; Mo J; Towbin A; Weiss B
    Pediatr Blood Cancer; 2011 Mar; 56(3):488-90. PubMed ID: 21225936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1.
    Jett K; Nguyen R; Arman D; Birch P; Chohan H; Farschtschi S; Fuensterer C; Kluwe L; Friedman JM; Mautner VF
    Am J Med Genet A; 2015 Jul; 167(7):1518-24. PubMed ID: 25900062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.
    Akshintala S; Baldwin A; Liewehr DJ; Goodwin A; Blakeley JO; Gross AM; Steinberg SM; Dombi E; Widemann BC
    Neuro Oncol; 2020 Sep; 22(9):1368-1378. PubMed ID: 32152628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1.
    Gross AM; Singh G; Akshintala S; Baldwin A; Dombi E; Ukwuani S; Goodwin A; Liewehr DJ; Steinberg SM; Widemann BC
    Neuro Oncol; 2018 Nov; 20(12):1643-1651. PubMed ID: 29718344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plexiform neurofibroma of uterus: a rare manifestation of neurofibromatosis 1.
    Shahzad R; Younas F
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S22-3. PubMed ID: 24717994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1.
    Nguyen R; Dombi E; Widemann BC; Solomon J; Fuensterer C; Kluwe L; Friedman JM; Mautner VF
    Orphanet J Rare Dis; 2012 Oct; 7():75. PubMed ID: 23035791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
    Robertson KA; Nalepa G; Yang FC; Bowers DC; Ho CY; Hutchins GD; Croop JM; Vik TA; Denne SC; Parada LF; Hingtgen CM; Walsh LE; Yu M; Pradhan KR; Edwards-Brown MK; Cohen MD; Fletcher JW; Travers JB; Staser KW; Lee MW; Sherman MR; Davis CJ; Miller LC; Ingram DA; Clapp DW
    Lancet Oncol; 2012 Dec; 13(12):1218-24. PubMed ID: 23099009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.
    Mautner VF; Hartmann M; Kluwe L; Friedrich RE; Fünsterer C
    Neuroradiology; 2006 Mar; 48(3):160-5. PubMed ID: 16432718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.